No. J0153 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDCs are billed under J0153?

CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 28 NDCs under J0153, for Adenosine. The table on this page shows each one with its billing units per package.

What is the Medicare payment limit for J0153?

$0.378 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

What is one billing unit of J0153?

One unit of J0153 is 1 mg (not to be used to report any adenosine phosphate compounds), as stated in the code's descriptor. Units to report = dose given ÷ 1 mg (not to be used to report any adenosine phosphate compounds).

J0153 J-Code: Adenosine — Billing Units & NDCs

In short

J0153 is the HCPCS Level II code for injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds). CMS assigns NDCs for Adenosine to it. One billing unit is 1 mg (not to be used to report any adenosine phosphate compounds). The Medicare Part B payment limit is $0.378 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ0153

Billing unit1 mg (not to be used to report any adenosine phosphate compounds)

Descriptor: Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
Short descriptor: Adenosine inj 1mg
Code set: HCPCS Level II, maintained by CMS
Effective: Jan 1, 2015

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$0.378

Per1 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 1 mg (not to be used to report any adenosine phosphate compounds). For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Dose given (mg)

HCPCS units (1 unit = 1 mg)

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the dose given to build the claim line.

NDCs billed under J0153

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 28 NDCs to J0153 for Adenosine. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J0153 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Adenosine	00404-9809-02	Henry Schein Inc.	2	6
Adenosine	00404-9993-02	Henry Schein Inc.	2	6
Adenosine	16714-0556-01	Northstar RxLLC	20	60
Adenosine	16714-0997-01	Northstar RxLLC	30	90
Adenosine	25021-0301-67	Sagent Pharmaceuticals	10 × 2	60
Adenosine	25021-0301-68	Sagent Pharmaceuticals	10 × 4	120
Adenosine	25021-0318-02	Sagent Pharmaceuticals	10 × 2	60
Adenosine	25021-0318-04	Sagent Pharmaceuticals	10 × 4	120
Adenosine	51662-1450-01	HF Acquisition Co. LLC, DBA HealthFirst	4	12
Adenosine	51662-1450-03	HF Acquisition Co. LLC, DBA HealthFirst	10 × 4	120
Adenosine	51662-1511-01	HF Acquisition Co. LLC, DBA HealthFirst	4	12
Adenosine	51662-1632-01	HF Acquisition Co. LLC, DBA HealthFirst	2	6
Adenosine	51662-1643-03	HF Acquisition Co. LLC, DBA HealthFirst	10 × 4	120
Adenosine	55150-0192-01	Eugia US LLC	20	60
Adenosine	55150-0193-01	Eugia US LLC	30	90
Adenosine	63323-0651-02	FreseniUS Kabi USA, LLC	10 × 2	60
Adenosine	63323-0651-04	FreseniUS Kabi USA, LLC	10 × 4	120
Adenosine	63323-0651-20	FreseniUS Kabi USA, LLC	20	60
Adenosine	63323-0651-30	FreseniUS Kabi USA, LLC	30	90
Adenosine	63323-0651-89	FreseniUS Kabi USA, LLC	10 × 2	60
Adenosine	63323-0651-90	FreseniUS Kabi USA, LLC	10 × 4	120
Adenosine	67457-0854-04	Mylan Institutional LLC	10 × 4	120
Adenosine	67457-0855-02	Mylan Institutional LLC	10 × 2	60
Adenosine	67457-0856-20	Mylan Institutional LLC	20	60
Adenosine	67457-0857-30	Mylan Institutional LLC	30	90
Adenosine	71288-0207-21	Meitheal Pharmaceuticals Inc.	10 × 20	600
Adenosine	71288-0208-30	Meitheal Pharmaceuticals Inc.	30	90
Adenosine	72078-0033-02	Mylan Institutional LLC	10 × 2	60

J0153: common questions

Is J0153 a CPT code?: No. J0153 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J0153?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 28 NDCs under J0153, for Adenosine. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J0153?: $0.378 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J0153?: One unit of J0153 is 1 mg (not to be used to report any adenosine phosphate compounds), as stated in the code's descriptor. Units to report = dose given ÷ 1 mg (not to be used to report any adenosine phosphate compounds). J-code billing units.

J0153 — Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)